External Advisory Board

The scientific work of IRB Barcelona is regularly assessed by an External Advisory Board which comprises 15 leading international researchers in biomedicine. Its main task is to provide guidance in shaping our research and related activities.

MEMBERS

Hans Clevers
The Netherlands Institute of Developmental Biology, Utrecht - Netherlands

Michael Czech
Professor of Molecular Medicine, University of Massachussets Medical School - U.S.A.

Christopher M. Dobson
Dept. of Chemistry & Physics, University of Cambridge - U.K.

José Elguero
Consejo Superior de Investigaciones Científicas (CSIC) - Spain

Samuel H. Gellman
Faculty of Chemistry, University of Wisconsin - U.S.A.

David M. Glover
Dept. of Genetics, University of Cambridge - U.K.

Jan-Ake Gustafsson
Director, Center for Biotechnology, Karolinska Institute - Sweden

Andrew Hamilton
Dept. of Chemistry, Yale University - U.S.A.

Robert Huber
Max-Planck-Institute für Biochemie - Germany

Tim Hunt
Imperial Cancer Research Fund - U.K.

Fotis Kafatos
Chair in Inmunogenomics, Imperial College (London) - U.K.

Bernd Meyer
Institute for Organic Chemistry, University of Hamburg - Germany

Charles J. Sherr
Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital - U.S.A

Bruce Spiegelman
Professor of Cell Biology, Harvard Medical School - U.S.A.

Karen Vousden
Director, Beatson Institute for Cancer Research - U.K.